ATE62507T1 - Molekulare klonierung und charakterisierung einer anderen gensequenz die fuer menschliches relaxin kodiert. - Google Patents

Molekulare klonierung und charakterisierung einer anderen gensequenz die fuer menschliches relaxin kodiert.

Info

Publication number
ATE62507T1
ATE62507T1 AT83307553T AT83307553T ATE62507T1 AT E62507 T1 ATE62507 T1 AT E62507T1 AT 83307553 T AT83307553 T AT 83307553T AT 83307553 T AT83307553 T AT 83307553T AT E62507 T1 ATE62507 T1 AT E62507T1
Authority
AT
Austria
Prior art keywords
characterization
sequence encoding
molecular cloning
gene sequence
encoding human
Prior art date
Application number
AT83307553T
Other languages
English (en)
Inventor
Peter John Hudson
Hugh David Niall
Geoffrey William Tregear
Original Assignee
Florey Howard Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3769889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE62507(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Florey Howard Inst filed Critical Florey Howard Inst
Application granted granted Critical
Publication of ATE62507T1 publication Critical patent/ATE62507T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
AT83307553T 1982-12-13 1983-12-12 Molekulare klonierung und charakterisierung einer anderen gensequenz die fuer menschliches relaxin kodiert. ATE62507T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPF724782 1982-12-13
EP83307553A EP0112149B1 (de) 1982-12-13 1983-12-12 Molekulare Klonierung und Charakterisierung einer anderen Gensequenz die für menschliches Relaxin kodiert

Publications (1)

Publication Number Publication Date
ATE62507T1 true ATE62507T1 (de) 1991-04-15

Family

ID=3769889

Family Applications (2)

Application Number Title Priority Date Filing Date
AT88110103T ATE90360T1 (de) 1982-12-13 1983-12-12 Molekulare klonierung und charakterisierung einer weiteren gen-sequenz, die fuer menschliches relaxin kodiert.
AT83307553T ATE62507T1 (de) 1982-12-13 1983-12-12 Molekulare klonierung und charakterisierung einer anderen gensequenz die fuer menschliches relaxin kodiert.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT88110103T ATE90360T1 (de) 1982-12-13 1983-12-12 Molekulare klonierung und charakterisierung einer weiteren gen-sequenz, die fuer menschliches relaxin kodiert.

Country Status (14)

Country Link
US (1) US4758516A (de)
EP (2) EP0112149B1 (de)
JP (3) JP2545055B2 (de)
KR (1) KR940002536B1 (de)
AT (2) ATE90360T1 (de)
CA (1) CA1220735A (de)
DE (1) DE3382249D1 (de)
DK (2) DK171684B1 (de)
ES (6) ES527964A0 (de)
HU (1) HU197767B (de)
IE (1) IE63902B1 (de)
IL (1) IL70414A (de)
NZ (1) NZ206534A (de)
ZA (1) ZA839231B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69469A (en) * 1982-08-12 1991-06-10 Florey Howard Inst Polypeptide having human h1-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
US5179195A (en) * 1982-12-13 1993-01-12 Howard Florey Institute Of Experimental Physiology And Medicine Human relaxin polypeptides
US4835251A (en) * 1986-06-23 1989-05-30 Genetech, Inc. Method of chain combination
AU612594B2 (en) * 1986-09-12 1991-07-18 Genentech Inc. Human prorelaxin
AU626840B2 (en) * 1988-02-26 1992-08-13 Genentech Inc. Human relaxin formulation
JP2857684B2 (ja) * 1989-05-04 1999-02-17 ジェネンテク，インコーポレイテッド ヒトリラキシンの単離のための方法および組成物
US5089419A (en) * 1989-08-07 1992-02-18 International Canine Genetics Detection of pregnancy by identification of the c peptide of relaxin in the urine of animals
US5166191A (en) * 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy
US5478807A (en) * 1991-08-19 1995-12-26 Genentech, Inc. Use of relaxin in the treatment of bradycardia
WO1993009436A1 (en) * 1991-10-28 1993-05-13 Board Of Regents, The University Of Texas System A method for detecting a differentiation marker in normal and carcinoma cells and in biological samples and body fluid
US6348327B1 (en) 1991-12-06 2002-02-19 Genentech, Inc. Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
EP0707650B1 (de) * 1993-06-21 2003-05-21 Genentech, Inc. Verfahren zur Herstellung von humanen Relaxin
US20050032683A1 (en) * 2000-10-04 2005-02-10 Amento Edward P. Methods of modulating apoptosis by administration of relaxin agonists or antagonists
US20040006205A1 (en) * 2001-04-03 2004-01-08 Li Li Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003016487A2 (en) * 2001-08-17 2003-02-27 The Board Of Trustees Of The Leland Stanford Junior University Mammalian relaxin receptors
AU2003903124A0 (en) * 2003-06-20 2003-07-10 Mark Del Borgo Analogues of heteromeric proteins
EP1753449A4 (de) * 2004-04-30 2009-09-23 Corthera Inc Verfahren und zusammensetzungen zur steuerung des fötalen wachstums mittels relaxin-modulation
US20060052304A1 (en) * 2004-09-02 2006-03-09 Bas Medical, Inc. Method for remodeling bone and related sutures
JP5653346B2 (ja) * 2008-05-16 2015-01-14 コーセラ，インコーポレーテッド 子宮頚管の拡張の予防方法
GR1006941B (el) 2009-06-01 2010-08-27 Χημικα Και Βιοφαρμακευτικα Εργαστηρια Πατρων Αε (Cbl-Patras), Πεπτιδικη συνθεση (peptide synthesis)
US8389475B2 (en) 2009-08-10 2013-03-05 The Board Of Trustees Of The Leland Stanford Junior University Relaxin analogs
MA34521B1 (fr) * 2010-08-17 2013-09-02 Ambrx Inc Polypeptides de relaxine modifiés et leurs utilisations
KR20140054009A (ko) 2011-07-01 2014-05-08 바이엘 인텔렉쳐 프로퍼티 게엠베하 릴랙신 융합 폴리펩타이드 및 그의 용도
EP2630964A1 (de) 2012-02-22 2013-08-28 Immundiagnostik AG Verfahren und Medikation zur Behandlung von Patienten mit Risiko für Prädiabetes und Typ-2-Diabetes
EP3068891A1 (de) 2013-11-13 2016-09-21 Aequus Biopharma Inc. Manipulierte glycoproteine und verwendungen davon
EP2946788A1 (de) 2014-05-23 2015-11-25 Immundiagnostik AG Verfahren und Zusammensetzung zur Behandlung von Herzversagen mit erhaltener Austreibungsfraktion
JP7088911B2 (ja) 2016-05-18 2022-06-21 モデルナティエックス インコーポレイテッド リラキシンをコードするポリヌクレオチド
SG11201907209QA (en) 2017-02-08 2019-09-27 Bristol Myers Squibb Co Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468464A (en) * 1974-11-04 1984-08-28 The Board Of Trustees Of The Leland Stanford Junior University Biologically functional molecular chimeras
GR70279B (de) * 1979-09-12 1982-09-03 Univ California
US4267101A (en) * 1980-02-01 1981-05-12 Serono Laboratories Inc. Process for obtaining human relaxin from fetal membranes
EP0068375A3 (de) * 1981-06-22 1983-04-13 G.D. Searle & Co. Rekombinante DNS Technik zur Herstellung von Relaxin
IE55479B1 (en) * 1982-02-12 1990-09-26 Florey Howard Inst Molecular cloning and characterization of the gene sequence coding for porcine relaxin
IL69469A (en) * 1982-08-12 1991-06-10 Florey Howard Inst Polypeptide having human h1-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors

Also Published As

Publication number Publication date
JP2545055B2 (ja) 1996-10-16
EP0112149A2 (de) 1984-06-27
ES544293A0 (es) 1988-04-16
ES8802249A1 (es) 1988-04-16
DK143492D0 (da) 1992-11-30
IE832908L (en) 1984-06-13
JP2891882B2 (ja) 1999-05-17
ES8801675A1 (es) 1988-02-16
ES552093A0 (es) 1987-09-01
ATE90360T1 (de) 1993-06-15
DK573783D0 (da) 1983-12-13
DK172012B1 (da) 1997-09-15
IL70414A (en) 1991-06-10
KR940002536B1 (ko) 1994-03-25
ES552094A0 (es) 1987-09-01
ES8708015A1 (es) 1987-09-01
IE63902B1 (en) 1995-06-14
ES8708016A1 (es) 1987-09-01
EP0303033A2 (de) 1989-02-15
HU197767B (en) 1989-05-29
EP0112149A3 (en) 1985-05-22
EP0303033B1 (de) 1993-06-09
NZ206534A (en) 1988-05-30
DE3382249D1 (de) 1991-05-16
JPH06100585A (ja) 1994-04-12
IL70414A0 (en) 1984-03-30
EP0112149B1 (de) 1991-04-10
ES557531A0 (es) 1988-02-16
KR840007024A (ko) 1984-12-04
JPS59156284A (ja) 1984-09-05
ZA839231B (en) 1984-08-29
ES8801373A1 (es) 1987-12-16
ES8602133A1 (es) 1985-11-16
DK573783A (da) 1984-06-14
CA1220735A (en) 1987-04-21
DK143492A (da) 1992-11-30
JPH07173198A (ja) 1995-07-11
EP0303033A3 (en) 1989-10-25
ES552095A0 (es) 1987-12-16
JP2677332B2 (ja) 1997-11-17
US4758516A (en) 1988-07-19
ES527964A0 (es) 1985-11-16
DK171684B1 (da) 1997-03-10

Similar Documents

Publication Publication Date Title
ATE62507T1 (de) Molekulare klonierung und charakterisierung einer anderen gensequenz die fuer menschliches relaxin kodiert.
ATE151111T1 (de) Rekombinante dns-verfahren und dadurch hergestellte produkte
DE3751104T2 (de) Polyfluorpolyäther mit Perfluoralkoxy-Seitengruppen.
DE3382117D1 (de) Molekulare klonierung und charakterisierung der das menschliche relaxin kodierenden gen-sequenz.
DE69013811D1 (de) Verfahren zur Herstellung von antiviralem Protein unter Benützung von E.coli-Transformant, das Gen, das für dieses Protein kodiert und E.coli-Vektor benützt in diesem Verfahren.
DE3764611D1 (de) Guertelreifen.
EP0273800A3 (en) Hirudine variants, their use and preparation
DE3585890D1 (de) Peptid und dafuer kodierendes gen.
DE3764206D1 (de) Schnittfeste ummantelung fuer seile, gurte, riemen, aufblasbare gegenstaende und aehnliches.
DE69534738D1 (de) Leukocyten-aktivierender Faktor
DE3785482D1 (de) Hochfestigkeit und hochbiegsamkeit erzeugende polymerzusammensetzung.
DE3382692T2 (de) Molekulare klonierung und charakterisierung einer weiteren gen-sequenz, die fuer menschliches relaxin kodiert.
DE3780388D1 (de) Fsh-stimulierendes peptid.
EP0288901A3 (en) Recombinant human glutathione peroxidase, process for preparing the same and dna coding the same
DE59002296D1 (de) Verfahren zur herstellung von in 4,4'-stellung dihalogenierten oligophenylen.
DE59000336D1 (de) Mischung aus mehlsorten und kleie fuer die herstellung von soja-pizza.
DE59203825D1 (de) Verfahren zur Herstellung von 1,2-Bis-(2-nitrophenoxy)-ethan.
ATE60089T1 (de) Molekulare klonierung und charakterisierung der das menschliche relaxin kodierenden gen-sequenz.
ATE75255T1 (de) Peptid und dafuer kodierendes gen.
IT8507116V0 (it) Apparecchio e stampo per la pieghettatura di pellami naturali o sintetici, tessuti e simili.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time